Annual Report

The report shows Taiyen Biotech's 2020 consolidated revenue rising to NT$3,130,347,000, up 7.7% from 2019. It also describes environmental controls across factories, ISO 14064-1 greenhouse-gas management, and externally verified emissions data. The company reports a GRI Standards Core Option CSR report assured by EY Taiwan under limited assurance. Governance disclosures include a Corporate Social Responsibility Committee and stakeholder-based material-topic prioritization.

Report type

Annual Report with Sustainability Disclosures

Class

Financial

Scope

Full report

Fiscal year

2020

Period

1 January 2020 – 31 December 2020

Publication date

19 May 2021

Language

English

Pages

 

File size

 

GRI

••••••

SASB

••••••

TCFD

••••••

ISSB

••••••

ESRS

••••••

Integrated Reporting Framework

••••••

GHG Protocol

••••••

EU Taxonomy

••••••

CDP

••••••

Other

••••••

GRI level

••••••

Assessment

••••••

Basis

••••••

Provider

••••••

Level

••••••

Standard

••••••

Scope

••••••

Statement included

••••••

Metrics assured

••••••